Predictors of Mortality in Patients With Cardiovascular Implantable Electronic Device Infections

被引:73
|
作者
Habib, Ammar [1 ]
Le, Katherine Y. [1 ]
Baddour, Larry M. [2 ]
Friedman, Paul A. [3 ]
Hayes, David L. [3 ]
Lohse, Christine M. [4 ]
Wilson, Walter R. [2 ]
Steckelberg, James M. [2 ]
Sohail, M. Rizwan [2 ]
机构
[1] Mayo Clin, Mayo Sch Grad Med Educ, Rochester, MN USA
[2] Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Dept Med, Div Cardiovasc Dis, Rochester, MN USA
[4] Mayo Clin, Coll Med, Dept Biostat & Informat, Rochester, MN USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 111卷 / 06期
关键词
RISK; PACEMAKER; OUTCOMES;
D O I
10.1016/j.amjcard.2012.11.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infection reduces survival in cardiovascular implantable electronic device (CIED) recipients. However, the clinical predictors of short- and long-term mortality in patients with CIED infection are not well understood. We retrospectively reviewed all patients with CIED infection who were admitted to Mayo Clinic from January 1991 to December 2008. Survival data were obtained from the medical records and the United Sates Social Security Index. The purported risk factors for short-term (30-day) and long-term (>30-day) mortality were analyzed using univariate and multivariate models. Overall, 415 cases of CIED infection were identified during the study period. The mean follow-up duration for the 243 patients who were alive at the last follow-up visit was 6.9 years. In a multivariate model, heart failure (odds ratio 9.31, 95% confidence interval 2.08 to 41.67), corticosteroid therapy (odds ratio 4.04, 95% confidence interval 1.40 to 11.60), and presentation with CIED-related infective endocarditis (odds ratio 5.60, 95% confidence interval 2.25 to 13.92) were associated with increased short-term mortality. The factors associated with long-term mortality in the multivariate model included patient age (hazard ratio 1.20, 95% confidence interval 1.06 to 1.36), heart failure (hazard ratio 2.01, 95% confidence interval 1.42 to 2.86), metastatic malignancy (hazard ratio 5.99, 95% confidence interval 1.67 to 21.53), corticosteroid therapy (hazard ratio 1.97, 95% confidence interval 1.22 to 3.18), renal failure (hazard ratio 1.94, 95% confidence interval 1.37 to 2.74), and CIED-related infective endocarditis (hazard ratio 1.68, 95% confidence interval 1.17 to 2.41). In conclusion, these data suggest that the development of CIED-related infective endocarditis and the presence of co-morbid conditions are associated with increased short- and long-term mortality in patients with CIED infection. (C) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111:874-879)
引用
收藏
页码:874 / 879
页数:6
相关论文
共 50 条
  • [1] Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections
    Le, Katherine Y.
    Sohail, Muhammad R.
    Friedman, Paul A.
    Uslan, Daniel Z.
    Cha, Stephen S.
    Hayes, David L.
    Wilson, Walter R.
    Steckelberg, James M.
    Baddour, Larry M.
    [J]. HEART RHYTHM, 2011, 8 (11) : 1678 - 1685
  • [2] Mortality and Cost Associated With Cardiovascular Implantable Electronic Device Infections
    Sohail, Muhammad R.
    Henrikson, Charles A.
    Braid-Forbes, Mary Jo
    Forbes, Kevin F.
    Lerner, Daniel J.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (20) : 1821 - 1828
  • [3] Increased Long-Term Mortality in Patients with Cardiovascular Implantable Electronic Device Infections
    Sohail, Muhammad Rizwan
    Henrikson, Charles A.
    Braid-Forbes, Mary Jo
    Forbes, Kevin F.
    Lerner, Daniel J.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02): : 231 - 239
  • [4] Cardiovascular Implantable Electronic Device Infections
    Arnold, Christopher J.
    Chu, Vivian H.
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2018, 32 (04) : 811 - +
  • [5] CLINICAL PREDICTORS OF MORTALITY WITH INTRACARDIAC CARDIOVASCULAR ELECTRONIC DEVICE INFECTIONS
    Kim, David H.
    Dresen, William
    Baker, Michael
    Tate, Jesalyn A.
    Bloch, Karen
    Kalams, Spyros
    Ellis, Christopher
    Lenihan, Daniel
    Mendes, Lisa
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E712 - E712
  • [6] Cardiovascular Implantable Electronic Device Associated Infections
    Gandhi, Tejal
    Crawford, Thomas
    Riddell, James
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (01) : 57 - +
  • [7] Procalcitonin in cardiovascular implantable electronic device infections
    Sedehi, D.
    Siddiqi, N.
    Shrestha, N.
    Agarwal, S.
    Tarakji, K.
    Wazni, O.
    Menon, V.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 100 - 100
  • [8] IMPACT OF TIMING OF DEVICE REMOVAL ON OUTCOMES IN PATIENTS WITH CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTIONS
    Cummings, Shenae
    Bensler, James Michael
    Hall, Michael E.
    Hernandez, Gabriel Antonio
    McMullan, Michael R.
    Sohail, Muhammad
    Garrigos, Zerelda E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 141 - 141
  • [9] Comparison of Mortality in Women Versus Men With Infections Involving Cardiovascular Implantable Electronic Device
    Sohail, M. Rizwan
    Henrikson, Charles A.
    Braid-Forbes, Mary Jo
    Forbes, Kevin F.
    Lerner, Daniel J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (09): : 1403 - 1409
  • [10] Differences of Mortality Rates between Pocket and Nonpocket Cardiovascular Implantable Electronic Device Infections
    Lee, Dong Heun
    Gracely, Edward J.
    Aleem, Sarah Y.
    Kutalek, Steven P.
    Vielemeyer, Ole
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (12): : 1456 - 1463